ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Pegasus Laboratories, Inc.
An Analytical Chemist I at PBI-Gordon Companies is an entry-level laboratory professional who supports the company's product quality and regulatory compliance in a cGMP environment. The role is based in Pensacola, FL and contributes to the company’s mission of integrity, innovation, and employee ownership.
Headquarters
Pensacola, Florida, United States
Company Size
51-200 employees
Founded
1986
Pegasus Laboratories, Inc. is a pharmaceutical company focused on developing, manufacturing, and marketing animal health and related products, including brands such as PRN Pharmacal.
PR NewswirePBI-Gordon Companies Acquires TriviumVet, Expanding Portfolio of Innovative Treatments in Pet Health
May 5, 2025
DVM360PRN Pharmacal acquires VPL; Bimeda and Ceva announce agreement on equine
Jan 10, 2020
Business WireFelycin®-CA1 (Sirolimus Delayed-Release Tablets) is the First and Only Drug FDA Approved for the Management of Ventricular Hypertrophy in Cats with Subclinical Hypertrophic Cardiomyopathy (HCM), A Condition Affecting as Many as One in Seven Cats
Jul 30, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Pegasus Laboratories, Inc..
Pegasus Laboratories, Inc. didn’t post a salary, so this is our estimate from similar listings.
Vet CandyFelycin®-CA1 is the First and Only Drug FDA Conditionally Approved for the Management of Ventricular Hypertrophy in Cats
Oct 9, 2025